Home

Balaxi Pharmaceuticals Ltd EPS

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

EPS

₹ 2.63

Last updated on: Dec 19, 2025

Key Highlights

  • The Earning per Share of Balaxi Pharmaceuticals Ltd is ₹ 2.63 as of 19 Dec 25 .
  • The earning per share of Balaxi Pharmaceuticals Ltd changed from ₹ -40.49 to ₹ 0.04 over 10 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Balaxi Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Balaxi Pharmaceuticals Ltd

Market Price of Balaxi Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
19 Dec 202527.83
18 Dec 202528.11
17 Dec 202528.82
16 Dec 202528.71
15 Dec 202529.04
12 Dec 202530.06
11 Dec 202533.02
10 Dec 202532.47
09 Dec 202532.13
08 Dec 202532.67

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Balaxi Pharmaceuticals Ltd

Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd

Market Value

154

-0.4 X

Value addition

Asset Value

243

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Balaxi Pharmaceuticals Ltd153.64
Sun Pharmaceutical Industries Ltd418708
Divis Laboratories Ltd171975
Torrent Pharmaceuticals Ltd128614
Cipla Ltd122539
Dr Reddys Laboratories Ltd106741

Historical Market Cap of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Balaxi Pharmaceuticals Ltd News Hub

Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter

Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga

Read more

02 Aug 24

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he

Read more

01 Aug 24

Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September

Read more

05 Nov 24

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20

Read more

30 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Balaxi Pharmaceuticals Ltd

What is the EPS of Balaxi Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Balaxi Pharmaceuticals Ltd is 2.63. An EPS is the amount of net income attributed to each share of a common stock.

How is Balaxi Pharmaceuticals Ltd EPS calculated?

The EPS of Balaxi Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Balaxi Pharmaceuticals Ltd report its EPS?

Balaxi Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Balaxi Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Balaxi Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Balaxi Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Balaxi Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions